Menu

Four drugmakers announced 340B refunds to covered entities, while another unveiled a change to the NDC for a 340B-priced drug.

4 Drugmakers to Refund CEs, 1 Announces NDC Change

September 22, 2026 Shannon Young, Managing Editor 340B Report Views

Four drugmakers recently informed covered entities that they will receive refunds following 340B ceiling price recalculations, while another announced a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Longtime Healthcare Executive, 340B Critic Arrested on Child Pornography-Related Charges

Fed Appeals Court Denies Novartis’ Bid to Rehear Missouri 340B Case